Home ➤ Life Science ➤ Diagnostics ➤ Legionnaire Disease Testing Market
Legionnaire Disease Testing Market
Published date: Oct 2025 • Formats:
[email protected] +1 718 874 1545
Request Sample Schedule a Call

Table of Contents

Legionnaire Disease Testing MarketLegionnaire Disease Testing Market By Product Type (Devices, Test Kits, Sequencer System, Rapid Test Kits, Polymerase Chain Reaction System, and Assay Based Test Kits), By Diagnostic Test (Urinary Antigen Test, Polymerase Chain Reaction, Paired Serology, Direct Fluorescent Antibody Stain, Culture Method, and Combination Testing), By End User (Hospitals, Research Centers, Diagnostic Laboratories, Clinical Research Centers, Academic Institutes, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Oct 2025
  • Report ID: 162908
  • Number of Pages: 219
  • Format:
Fact Checked
Legionnaire Disease Testing Market https://market.us/report/legionnaire-disease-testing-market/
Cite this Research
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Legionnaire Disease Testing Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Legionnaire Disease Testing Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Legionnaire Disease Testing Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
        • 3.3.1. Devices
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Test kits
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Sequencer system
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Rapid test kits
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
        • 3.3.5. Polymerase chain reaction system
          • 3.3.5.1. Insights
          • 3.3.5.2. Key Takeaways
        • 3.3.6. Assay-based test kits
          • 3.3.6.1. Insights
          • 3.3.6.2. Key Takeaways
      • 3.4. Global Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Diagnostic Test, 2020-2034
      • 3.5. Global Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
        • 3.5.1. Urinary antigen test
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Polymerase chain reaction
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Paired serology
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Direct fluorescent antibody stain
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Culture method
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
        • 3.5.6. Combination testing
          • 3.5.6.1. Insights
          • 3.5.6.2. Key Takeaways
      • 3.6. Global Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.7. Global Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
        • 3.7.1. Hospitals
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Research centers
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Diagnostic laboratories
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Clinical research centers
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
        • 3.7.5. Academic institutes
          • 3.7.5.1. Insights
          • 3.7.5.2. Key Takeaways
    • 4. Global Legionnaire Disease Testing Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Legionnaire Disease Testing Market Attractiveness Analysis, By Region
    • 5. North America Legionnaire Disease Testing Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • 5.4. North America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Diagnostic Test, 2020-2034
      • 5.5. North America Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • 5.6. North America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.7. North America Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • 5.8. North America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Legionnaire Disease Testing Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Legionnaire Disease Testing Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Diagnostic Test, 2020-2034
      • 6.5. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • 6.6. Europe Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.7. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • 6.8. Europe Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Legionnaire Disease Testing Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Diagnostic Test, 2020-2034
      • 7.5. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • 7.6. Asia Pacific Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.7. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • 7.8. Asia Pacific Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Legionnaire Disease Testing Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Diagnostic Test, 2020-2034
      • 8.5. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • 8.6. Latin America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.7. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • 8.8. Latin America Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Legionnaire Disease Testing Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Diagnostic Test, 2020-2034
      • 9.5. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • 9.6. Middle East & Africa Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.7. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • 9.8. Middle East & Africa Legionnaire Disease Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Thermo Fisher Scientific Inc.
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. QIAGEN N.V.
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Merck KGaA
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. IDEXX Laboratories Inc.
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Eurofins Scientific
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Eiken Chemical Co., Ltd.
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Bio-Rad Laboratories, Inc.
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. bioMérieux SA
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Becton, Dickinson and Company (BD)
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Abbott Laboratories
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 2. Global Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 3. Global Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 4. Global Legionnaire Disease Testing Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 6. North America Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 7. North America Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 8. North America Legionnaire Disease Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 10. The US Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 11. The US Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 12. Canada Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 13. Canada Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 14. Canada Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 15. Europe Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 16. Europe Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 17. Europe Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 18. Europe Legionnaire Disease Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 20. Germany Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 21. Germany Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 22. The UK Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 23. The UK Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 24. The UK Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 25. France Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 26. France Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 27. France Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 28. Spain Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 29. Spain Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 30. Spain Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 31. Italy Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 32. Italy Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 33. Italy Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 34. Russia Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 35. Russia Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 36. Russia Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 37. Netherland Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 38. Netherland Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 39. Netherland Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 40. Rest of Europe Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 41. Rest of Europe Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 42. Rest of Europe Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 43. Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 44. Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 45. Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 46. Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 48. China Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 49. China Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 50. India Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 51. India Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 52. India Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 53. Japan Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 54. Japan Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 55. Japan Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 56. South Korea Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 57. South Korea Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 58. South Korea Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 59. Australia Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 60. Australia Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 61. Australia Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 62. New Zealand Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 63. New Zealand Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 64. New Zealand Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 65. Singapore Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 66. Singapore Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 67. Singapore Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 68. Thailand Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 69. Thailand Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 70. Thailand Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 71. Vietnam Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 72. Vietnam Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 73. Vietnam Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 74. Rest of Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 75. Rest of Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 76. Rest of Asia Pacific Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 77. Latin America Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 78. Latin America Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 79. Latin America Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 80. Latin America Legionnaire Disease Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 82. Brazil Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 83. Brazil Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 84. Mexico Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 85. Mexico Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 86. Mexico Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 87. Rest of Latin America Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 88. Rest of Latin America Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 89. Rest of Latin America Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 90. Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 91. Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 92. Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 93. Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 95. South Africa Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 96. South Africa Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 97. Saudi Arabia Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 98. Saudi Arabia Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 99. Saudi Arabia Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 100. UAE Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 101. UAE Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 102. UAE Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
      • Table 103. Rest of Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 104. Rest of Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By Diagnostic Test, 2020-2034
      • Table 105. Rest of Middle East & Africa Legionnaire Disease Testing Market Value (US$ Mn), By End-user, 2020-2034
    • List of Figures
      • Figure 1. Global Legionnaire Disease Testing Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Legionnaire Disease Testing Market
      • Figure 5. Global Legionnaire Disease Testing Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Legionnaire Disease Testing Market Analysis, By Diagnostic Test, 2020, 2024 and 2034
      • Figure 8. Global Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • Figure 9. Global Legionnaire Disease Testing Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 10. Global Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • Figure 11. Global Legionnaire Disease Testing Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Legionnaire Disease Testing Market Attractiveness Analysis, By Region
      • Figure 13. North America Legionnaire Disease Testing Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 14. North America Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • Figure 15. North America Legionnaire Disease Testing Market (US$ Mn), by Devices, 2020-2034
      • Figure 16. North America Legionnaire Disease Testing Market (US$ Mn), by Test kits, 2020-2034
      • Figure 17. North America Legionnaire Disease Testing Market (US$ Mn), by Sequencer system, 2020-2034
      • Figure 18. North America Legionnaire Disease Testing Market (US$ Mn), by Rapid test kits, 2020-2034
      • Figure 19. North America Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction system, 2020-2034
      • Figure 20. North America Legionnaire Disease Testing Market (US$ Mn), by Assay-based test kits, 2020-2034
      • Figure 21. North America Legionnaire Disease Testing Market Analysis, By Diagnostic Test, 2020, 2024 and 2034
      • Figure 22. North America Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • Figure 23. North America Legionnaire Disease Testing Market (US$ Mn), by Urinary antigen test, 2020-2034
      • Figure 24. North America Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction, 2020-2034
      • Figure 25. North America Legionnaire Disease Testing Market (US$ Mn), by Paired serology, 2020-2034
      • Figure 26. North America Legionnaire Disease Testing Market (US$ Mn), by Direct fluorescent antibody stain, 2020-2034
      • Figure 27. North America Legionnaire Disease Testing Market (US$ Mn), by Culture method, 2020-2034
      • Figure 28. North America Legionnaire Disease Testing Market (US$ Mn), by Combination testing, 2020-2034
      • Figure 29. North America Legionnaire Disease Testing Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 30. North America Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • Figure 31. North America Legionnaire Disease Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 32. North America Legionnaire Disease Testing Market (US$ Mn), by Research centers, 2020-2034
      • Figure 33. North America Legionnaire Disease Testing Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 34. North America Legionnaire Disease Testing Market (US$ Mn), by Clinical research centers, 2020-2034
      • Figure 35. North America Legionnaire Disease Testing Market (US$ Mn), by Academic institutes, 2020-2034
      • Figure 36. North America Legionnaire Disease Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 37. North America Legionnaire Disease Testing Market Attractiveness Analysis, By Country
      • Figure 38. Europe Legionnaire Disease Testing Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 39. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • Figure 40. Europe Legionnaire Disease Testing Market (US$ Mn), by Devices, 2020-2034
      • Figure 41. Europe Legionnaire Disease Testing Market (US$ Mn), by Test kits, 2020-2034
      • Figure 42. Europe Legionnaire Disease Testing Market (US$ Mn), by Sequencer system, 2020-2034
      • Figure 43. Europe Legionnaire Disease Testing Market (US$ Mn), by Rapid test kits, 2020-2034
      • Figure 44. Europe Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction system, 2020-2034
      • Figure 45. Europe Legionnaire Disease Testing Market (US$ Mn), by Assay-based test kits, 2020-2034
      • Figure 46. Europe Legionnaire Disease Testing Market Analysis, By Diagnostic Test, 2020, 2024 and 2034
      • Figure 47. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • Figure 48. Europe Legionnaire Disease Testing Market (US$ Mn), by Urinary antigen test, 2020-2034
      • Figure 49. Europe Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction, 2020-2034
      • Figure 50. Europe Legionnaire Disease Testing Market (US$ Mn), by Paired serology, 2020-2034
      • Figure 51. Europe Legionnaire Disease Testing Market (US$ Mn), by Direct fluorescent antibody stain, 2020-2034
      • Figure 52. Europe Legionnaire Disease Testing Market (US$ Mn), by Culture method, 2020-2034
      • Figure 53. Europe Legionnaire Disease Testing Market (US$ Mn), by Combination testing, 2020-2034
      • Figure 54. Europe Legionnaire Disease Testing Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 55. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • Figure 56. Europe Legionnaire Disease Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 57. Europe Legionnaire Disease Testing Market (US$ Mn), by Research centers, 2020-2034
      • Figure 58. Europe Legionnaire Disease Testing Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 59. Europe Legionnaire Disease Testing Market (US$ Mn), by Clinical research centers, 2020-2034
      • Figure 60. Europe Legionnaire Disease Testing Market (US$ Mn), by Academic institutes, 2020-2034
      • Figure 61. Europe Legionnaire Disease Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 62. Europe Legionnaire Disease Testing Market Attractiveness Analysis, By Country
      • Figure 63. Asia Pacific Legionnaire Disease Testing Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 64. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • Figure 65. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Devices, 2020-2034
      • Figure 66. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Test kits, 2020-2034
      • Figure 67. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Sequencer system, 2020-2034
      • Figure 68. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Rapid test kits, 2020-2034
      • Figure 69. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction system, 2020-2034
      • Figure 70. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Assay-based test kits, 2020-2034
      • Figure 71. Asia Pacific Legionnaire Disease Testing Market Analysis, By Diagnostic Test, 2020, 2024 and 2034
      • Figure 72. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • Figure 73. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Urinary antigen test, 2020-2034
      • Figure 74. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction, 2020-2034
      • Figure 75. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Paired serology, 2020-2034
      • Figure 76. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Direct fluorescent antibody stain, 2020-2034
      • Figure 77. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Culture method, 2020-2034
      • Figure 78. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Combination testing, 2020-2034
      • Figure 79. Asia Pacific Legionnaire Disease Testing Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 80. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • Figure 81. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 82. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Research centers, 2020-2034
      • Figure 83. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 84. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Clinical research centers, 2020-2034
      • Figure 85. Asia Pacific Legionnaire Disease Testing Market (US$ Mn), by Academic institutes, 2020-2034
      • Figure 86. Asia Pacific Legionnaire Disease Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 87. Asia Pacific Legionnaire Disease Testing Market Attractiveness Analysis, By Country
      • Figure 88. Latin America Legionnaire Disease Testing Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 89. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • Figure 90. Latin America Legionnaire Disease Testing Market (US$ Mn), by Devices, 2020-2034
      • Figure 91. Latin America Legionnaire Disease Testing Market (US$ Mn), by Test kits, 2020-2034
      • Figure 92. Latin America Legionnaire Disease Testing Market (US$ Mn), by Sequencer system, 2020-2034
      • Figure 93. Latin America Legionnaire Disease Testing Market (US$ Mn), by Rapid test kits, 2020-2034
      • Figure 94. Latin America Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction system, 2020-2034
      • Figure 95. Latin America Legionnaire Disease Testing Market (US$ Mn), by Assay-based test kits, 2020-2034
      • Figure 96. Latin America Legionnaire Disease Testing Market Analysis, By Diagnostic Test, 2020, 2024 and 2034
      • Figure 97. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • Figure 98. Latin America Legionnaire Disease Testing Market (US$ Mn), by Urinary antigen test, 2020-2034
      • Figure 99. Latin America Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction, 2020-2034
      • Figure 100. Latin America Legionnaire Disease Testing Market (US$ Mn), by Paired serology, 2020-2034
      • Figure 101. Latin America Legionnaire Disease Testing Market (US$ Mn), by Direct fluorescent antibody stain, 2020-2034
      • Figure 102. Latin America Legionnaire Disease Testing Market (US$ Mn), by Culture method, 2020-2034
      • Figure 103. Latin America Legionnaire Disease Testing Market (US$ Mn), by Combination testing, 2020-2034
      • Figure 104. Latin America Legionnaire Disease Testing Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 105. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • Figure 106. Latin America Legionnaire Disease Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 107. Latin America Legionnaire Disease Testing Market (US$ Mn), by Research centers, 2020-2034
      • Figure 108. Latin America Legionnaire Disease Testing Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 109. Latin America Legionnaire Disease Testing Market (US$ Mn), by Clinical research centers, 2020-2034
      • Figure 110. Latin America Legionnaire Disease Testing Market (US$ Mn), by Academic institutes, 2020-2034
      • Figure 111. Latin America Legionnaire Disease Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 112. Latin America Legionnaire Disease Testing Market Attractiveness Analysis, By Country
      • Figure 113. Middle East & Africa Legionnaire Disease Testing Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 114. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By Product Type
      • Figure 115. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Devices, 2020-2034
      • Figure 116. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Test kits, 2020-2034
      • Figure 117. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Sequencer system, 2020-2034
      • Figure 118. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Rapid test kits, 2020-2034
      • Figure 119. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction system, 2020-2034
      • Figure 120. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Assay-based test kits, 2020-2034
      • Figure 121. Middle East & Africa Legionnaire Disease Testing Market Analysis, By Diagnostic Test, 2020, 2024 and 2034
      • Figure 122. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By Diagnostic Test
      • Figure 123. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Urinary antigen test, 2020-2034
      • Figure 124. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Polymerase chain reaction, 2020-2034
      • Figure 125. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Paired serology, 2020-2034
      • Figure 126. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Direct fluorescent antibody stain, 2020-2034
      • Figure 127. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Culture method, 2020-2034
      • Figure 128. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Combination testing, 2020-2034
      • Figure 129. Middle East & Africa Legionnaire Disease Testing Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 130. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By End-user
      • Figure 131. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 132. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Research centers, 2020-2034
      • Figure 133. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Diagnostic laboratories, 2020-2034
      • Figure 134. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Clinical research centers, 2020-2034
      • Figure 135. Middle East & Africa Legionnaire Disease Testing Market (US$ Mn), by Academic institutes, 2020-2034
      • Figure 136. Middle East & Africa Legionnaire Disease Testing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 137. Middle East & Africa Legionnaire Disease Testing Market Attractiveness Analysis, By Country
    • Thermo Fisher Scientific Inc.
    • QIAGEN N.V.
    • Merck KGaA
    • IDEXX Laboratories Inc.
    • Eurofins Scientific
    • Eiken Chemical Co., Ltd.
    • Bio-Rad Laboratories, Inc.
    • bioMérieux SA
    • Becton, Dickinson and Company (BD)
    • Abbott Laboratories
Legionnaire Disease Testing Market
Legionnaire Disease Testing Market
Published date: Oct 2025
add_shopping_cartBuy Now get_appDownload Sample

Related Reports

Legionnaire Disease Testing Market
  • 162908
  • Oct 2025
    • ★★★★★
      ★★★★★
Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo

Our Clients

✖
Request a Sample Report
We'll get back to you as quickly as possible

✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options